Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 629-646
Open Access | Times Cited: 257

Showing 1-25 of 257 citing articles:

Seroconversion rates following COVID-19 vaccination among patients with cancer
Astha Thakkar, Jesus D. Gonzalez‐Lugo, Niyati Goradia, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1081-1090.e2
Open Access | Times Cited: 341
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper, et al.
Annals of Oncology (2021) Vol. 32, Iss. 6, pp. 787-800
Open Access | Times Cited: 294
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Alfredo Addeo, Pankil Shah, Natacha Bordry, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1091-1098.e2
Open Access | Times Cited: 227
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
Sidse Ehmsen, Anders Asmussen, Stefan Starup Jeppesen, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1034-1036
Open Access | Times Cited: 146
NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond
Yuanfeng Zhu, Xiaoli Chen, Xin Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 129
Severity of COVID-19 in patients with lung cancer: evidence and challenges
Antonio Passaro, Christine M. Bestvina, Maria Velez Velez, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e002266-e002266
Open Access | Times Cited: 121
Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021
Weiqiu Jin, Kaichen Huang, Zeyu Ding, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies
Lee M. Greenberger, Larry A. Saltzman, Jonathon W. Senefeld, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1297-1299
Open Access | Times Cited: 92
Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma
Adolfo Aleman, Bhaskar Upadhyaya, Kevin Tuballes, et al.
Cancer Cell (2021) Vol. 39, Iss. 11, pp. 1442-1444
Open Access | Times Cited: 71
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer
Sonali M. Smith, KERRI WACHTER, Howard A. Burris, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 10, pp. 1165-1184
Open Access | Times Cited: 70
The intersection of COVID-19 and cancer: signaling pathways and treatment implications
Zhi Zong, Yujun Wei, Jiang Ren, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 61
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Mario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, et al.
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1171-1172
Open Access | Times Cited: 61
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
Vivek Naranbhai, Claire A. Pernat, Alexander Gavralidis, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 1, pp. 12-23
Open Access | Times Cited: 61
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
Ziad Bakouny, Chris Labaki, Punita Grover, et al.
JAMA Oncology (2022) Vol. 9, Iss. 1, pp. 128-128
Open Access | Times Cited: 37
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
Toni K. Choueiri, Chris Labaki, Ziad Bakouny, et al.
The Lancet Regional Health - Americas (2023) Vol. 19, pp. 100445-100445
Open Access | Times Cited: 31
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches
Valeria Conti, Graziamaria Corbi, Francesco Sabbatino, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 334-334
Open Access | Times Cited: 28
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study
Andrew Schmidt, Ziad Bakouny, Sheena Bhalla, et al.
Cancer Cell (2020) Vol. 38, Iss. 6, pp. 769-770
Open Access | Times Cited: 65
COVID-19 and Cancer
Aakash Desai, Turab Mohammed, Narjust Duma, et al.
JAMA Oncology (2021) Vol. 7, Iss. 12, pp. 1882-1882
Open Access | Times Cited: 49
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
Saptarshi Sinha, Chanakya Nath Kundu
Medical Oncology (2021) Vol. 38, Iss. 9
Open Access | Times Cited: 44
The Impact of COVID‐19 on Head and Neck Cancer Treatment: Before and During the Pandemic
Roberto N. Solis, Mehrnaz Mehrzad, Samya Faiq, et al.
OTO Open (2021) Vol. 5, Iss. 4
Open Access | Times Cited: 42
Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
Bo He, Zhao Huang, Canhua Huang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2022) Vol. 16, Iss. 6
Closed Access | Times Cited: 36
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer
Vivek Naranbhai, Kerri St. Denis, Evan C. Lam, et al.
Cancer Cell (2022) Vol. 40, Iss. 1, pp. 103-108.e2
Open Access | Times Cited: 34
Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study
Ayşe İrem Yasin, Sabin Göktaş Aydın, Bilge Sümbül, et al.
Future Oncology (2022) Vol. 18, Iss. 10, pp. 1235-1244
Open Access | Times Cited: 30
Global analysis of within-host SARS-CoV-2/HIV coinfection model with latency
A. M. Ełaiw, Afnan Al Agha, S. A. Azoz, et al.
The European Physical Journal Plus (2022) Vol. 137, Iss. 2
Open Access | Times Cited: 28
Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany
Sven Voigtländer, Amir Hakimhashemi, Nina Grundmann, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7493-7503
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top